About the Advanced Regenerative Manufacturing Institute
Our mission is to advance the bioeconomy of the United States. The Institute’s work will positively impact not only manufacturing but also healthcare and education and workforce development for the nation.
Manufacturing scalability, process and partnership.
There are 400,000 people worldwide right now on waiting lists for organs. What if we could create lungs, livers or corneas at scale? It would be unprecedented.
Our goal is to move highly specialized regenerative medicine – engineering or regenerating human cells, tissues and organs – from lab to production to cure diseases and improve quality of life.
ARMI’s Leadership Team
DEAN KAMEN
Executive Director & Chairman of the Board, ARMI
Maureen Toohey
Deputy Executive Director & Secretary of the Board
Thomas Bollenbach, Ph.D.
Chief Technology Officer
Jim Scott
Chief Administrative Officer
Jennifer MacDonald, M.D.
Chief Operating Officer
News Highlights
Events
Events
-
-
ISSCR 2026 Annual Meeting
ARMI will attend the ISSCR 2026 Annual Meeting, the premier global gathering for stem cell research and regenerative medicine, to connect with scientific leaders and explore emerging advances shaping the future of the field.
-
BioTrekker Camp at SEE Science Center (Ages 11–14)
SEE Science Center 200 Bedford Street, Manchester, NH, United StatesA week-long, hands-on science camp for ages 11–14 exploring biotechnology, regenerative medicine, and real-world medical challenges—led by ARMI educators at the SEE Science Center.
-
-
Military Health System Research Symposium (MHSRS) 2026
Gaylord Palms Resort & Convention Center 6000 Osceola Pkwy, Kissimmee, FL, United StatesARMI will attend the 2026 Military Health System Research Symposium (MHSRS), the Department of Defense’s premier scientific meeting focused on military medical research, healthcare innovation, and warfighter readiness.
-
-
Cell & Gene Meeting on the Mesa 2026
Arizona Biltmore 2400 E Missouri Ave, Phoenix, AZ, United StatesARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry’s leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
